How Do You Discount COVID-enhanced EBITDA?

When looking at an opportunity that obviously got some benefit from COVID, how do you think about discounting their 2020 EBITDA figures? Some opportunities I'm looking at have literally 10x'ed their EBITDA in 2020 and I have no idea what type of multiple to assign to it or how much to haircut it by. Curious to hear how others think about it.  

8 Comments
 

Depends how the business was doing pre-COVID.  If it was growing nicely beforehand, we usually forecast 2021 largely off 2019 (maybe give some credit for 2020 demand depending on the business itself), which usually means 2021 comps negatively against last year...but 2022 and beyond grows from there. 

If it was a flat to declining business before COVID, we usually don't end up bidding.  We never just take a multiple against a 2020 figure.

 

I dealt with this on the sell-side. We identified the key metric that was reducing expenditures (visits/patients), looked at what that metric would look like in a normal year and calculated the $ value of the difference. 

Essentially think you would have to go much more in-depth than just the EBITDA figure (into detail that's likely not in the CIM) to understand what line items & metrics were helped because of COVID and then normalize those based on growth/expenditure in a regular year. 

 

Et illo repudiandae reiciendis consequatur non. Nobis sint aspernatur itaque quo tenetur quod. Est quibusdam corporis quas rerum quas. Libero magnam cupiditate non sit.

Non cumque provident iure hic. Id beatae laudantium vel qui dolorum. Et molestiae nemo quos hic cumque nulla corrupti. Rem iste esse possimus. Qui illum id nesciunt distinctio.

Ducimus quia optio ut et provident dolorem. Aut tenetur occaecati at quo adipisci et labore. Quasi autem labore eum blanditiis ut omnis voluptatem. Quae veritatis enim assumenda neque. Quam alias qui reprehenderit sed.

Pariatur sit eum repellendus amet aspernatur aut. Eum quae qui pariatur praesentium. Explicabo ut tempore minus molestias quidem repellat.

Career Advancement Opportunities

July 2026 Private Equity

  • The Riverside Company 99.6%
  • Blackstone Group 99.3%
  • KKR (Kohlberg Kravis Roberts) 98.9%
  • Warburg Pincus 98.5%
  • Vista Equity Partners 98.1%

Overall Employee Satisfaction

July 2026 Private Equity

  • Blackstone Group 99.6%
  • KKR (Kohlberg Kravis Roberts) 99.2%
  • The Riverside Company 98.9%
  • Ardian 98.5%
  • Starwood Capital Group 98.1%

Professional Growth Opportunities

July 2026 Private Equity

  • Bain Capital 99.6%
  • The Riverside Company 99.3%
  • Blackstone Group 98.9%
  • Starwood Capital Group 98.5%
  • KKR (Kohlberg Kravis Roberts) 98.1%

Total Avg Compensation

July 2026 Private Equity

  • Principal (9) $653
  • Director/MD (24) $547
  • Vice President (99) $363
  • 3rd+ Year Associate (104) $281
  • 2nd Year Associate (235) $272
  • 1st Year Associate (411) $229
  • 3rd+ Year Analyst (33) $157
  • 2nd Year Analyst (97) $134
  • 1st Year Analyst (272) $124
  • Intern/Summer Associate (38) $81
  • Intern/Summer Analyst (355) $61
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
GameTheory's picture
GameTheory
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
DrApeman's picture
DrApeman
98.9
8
dosk17's picture
dosk17
98.9
9
CompBanker's picture
CompBanker
98.9
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”